These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 28938710

  • 1. Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
    Bhupathiraju SN, Grodstein F, Rosner BA, Stampfer MJ, Hu FB, Willett WC, Manson JE.
    Am J Epidemiol; 2017 Sep 15; 186(6):696-708. PubMed ID: 28938710
    [Abstract] [Full Text] [Related]

  • 2. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
    Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB.
    JAMA; 2013 Oct 02; 310(13):1353-68. PubMed ID: 24084921
    [Abstract] [Full Text] [Related]

  • 3. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 02; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 4. Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women.
    Balasubramanian R, Demler O, Guasch-Ferré M, Paynter NP, Sheehan R, Liu S, Manson JE, Salas-Salvadó J, Martínez-Gonzalez MÁ, Hu FB, Clish C, Rexrode KM.
    Circ Genom Precis Med; 2020 Dec 02; 13(6):e002977. PubMed ID: 33141616
    [Abstract] [Full Text] [Related]

  • 5. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.
    J Steroid Biochem Mol Biol; 2014 Jul 02; 142():4-11. PubMed ID: 24172877
    [Abstract] [Full Text] [Related]

  • 6. Menopausal Hormone Therapy and Risks of First Hospitalized Heart Failure and its Subtypes During the Intervention and Extended Postintervention Follow-up of the Women's Health Initiative Randomized Trials.
    Liu L, Klein L, Eaton C, Panjrath G, Martin LW, Chae CU, Greenland P, Lloyd-Jones DM, Wactawski-Wende J, Manson JE.
    J Card Fail; 2020 Jan 02; 26(1):2-12. PubMed ID: 31536806
    [Abstract] [Full Text] [Related]

  • 7. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
    Manson JE, Bassuk SS, Kaunitz AM, Pinkerton JV.
    Menopause; 2020 Aug 02; 27(8):918-928. PubMed ID: 32345788
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J, Women's Health Initiative Memory Study.
    JAMA; 2004 Jun 23; 291(24):2959-68. PubMed ID: 15213207
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The WHI ten year's later: an epidemiologist's view.
    Lacey JV.
    J Steroid Biochem Mol Biol; 2014 Jul 23; 142():12-5. PubMed ID: 24029430
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials.
    Chlebowski RT, Aragaki AK, Pan K, Haque R, Rohan TE, Song M, Wactawski-Wende J, Lane DS, Harris HR, Strickler H, Kauntiz AM, Runowicz CD.
    J Clin Oncol; 2024 Oct 20; 42(30):3537-3549. PubMed ID: 39173088
    [Abstract] [Full Text] [Related]

  • 16. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML.
    JAMA; 2007 Apr 04; 297(13):1465-77. PubMed ID: 17405972
    [Abstract] [Full Text] [Related]

  • 17. Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.
    Jiang X, Nudy M, Aragaki AK, Robbins JA, Manson JE, Stefanick ML, OʼSullivan DM, Shikany JM, LeBlanc ES, Kelsey AM, Cauley J, Martin LW, Payne ME, Johnson KC, Howard B, Schnatz PF.
    Menopause; 2019 Aug 04; 26(8):841-849. PubMed ID: 31145202
    [Abstract] [Full Text] [Related]

  • 18. Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?
    Hodis HN, Sarrel PM.
    Climacteric; 2018 Dec 04; 21(6):521-528. PubMed ID: 30296850
    [Abstract] [Full Text] [Related]

  • 19. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ, Zuckerman IH, Lee E.
    J Womens Health (Larchmt); 2004 Nov 04; 13(9):986-92. PubMed ID: 15665655
    [Abstract] [Full Text] [Related]

  • 20. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
    Maki PM, Henderson VW.
    Climacteric; 2012 Jun 04; 15(3):256-62. PubMed ID: 22612612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.